These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24685927)

  • 1. Response.
    Brasky TM; Thompson IM; King IB; Kristal AR
    J Natl Cancer Inst; 2014 Apr; 106(4):dju021. PubMed ID: 24685927
    [No Abstract]   [Full Text] [Related]  

  • 2. What you should know about omega-3 fatty acids and prostate cancer.
    Stohs SJ; Goldberg K
    J Diet Suppl; 2014 Dec; 11(4):476-8. PubMed ID: 24689516
    [No Abstract]   [Full Text] [Related]  

  • 3. Omega-3 and prostate cancer: examining the pertinent evidence.
    McCarty MF; DiNicolantonio JJ; Lavie CJ; O'Keefe JH
    Mayo Clin Proc; 2014 Apr; 89(4):444-50. PubMed ID: 24613035
    [No Abstract]   [Full Text] [Related]  

  • 4. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Tokudome S; Ando R; Ichikawa Y; Ichikawa H; Imaeda N; Goto C; Tokudome Y; Okuyama H
    J Natl Cancer Inst; 2014 Apr; 106(4):dju020. PubMed ID: 24685933
    [No Abstract]   [Full Text] [Related]  

  • 5. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Cleland LG; Proudman SM; James MJ
    J Natl Cancer Inst; 2014 Apr; 106(4):dju022. PubMed ID: 24685932
    [No Abstract]   [Full Text] [Related]  

  • 6. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    McCarty MF; Dinicolantonio JJ; Lavie CJ; O'Keefe JH
    J Natl Cancer Inst; 2014 Apr; 106(4):dju014. PubMed ID: 24685931
    [No Abstract]   [Full Text] [Related]  

  • 7. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Torfadottir JE; Stampfer MJ; Mucci LA; Giovannucci EL
    J Natl Cancer Inst; 2014 Apr; 106(4):dju018. PubMed ID: 24685929
    [No Abstract]   [Full Text] [Related]  

  • 8. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Harris WS; Davidson MH
    J Natl Cancer Inst; 2014 Apr; 106(4):dju019. PubMed ID: 24685928
    [No Abstract]   [Full Text] [Related]  

  • 9. RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    McCulloch M; Alvarez E; Gendreau R; Haney S; Harrelson J; Luo R
    J Natl Cancer Inst; 2014 Apr; 106(4):dju024. PubMed ID: 24685926
    [No Abstract]   [Full Text] [Related]  

  • 10. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    El-Bayoumy K; Thompson H; Manni A
    J Natl Cancer Inst; 2014 Apr; 106(4):dju017. PubMed ID: 24685921
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Taneja SS
    J Urol; 2014 Mar; 191(3):658. PubMed ID: 24522035
    [No Abstract]   [Full Text] [Related]  

  • 12. Words of wisdom: Re: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Sosnowski R; Zawistowski J
    Eur Urol; 2014 May; 65(5):1012. PubMed ID: 24646497
    [No Abstract]   [Full Text] [Related]  

  • 13. Words of wisdom. Re: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Chow K; Murphy DG
    Eur Urol; 2013 Dec; 64(6):1015-6. PubMed ID: 24209450
    [No Abstract]   [Full Text] [Related]  

  • 14. RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Suburu J; Lim K; Calviello G; Chen YQ
    J Natl Cancer Inst; 2014 Apr; 106(4):dju023. PubMed ID: 24685923
    [No Abstract]   [Full Text] [Related]  

  • 15. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Brenna JT; Burdge GC; Crawford MA; Clayton P; Cunnane SC; Gow R; Hibbeln JR; Sinclair AJ; Stein J; Willatts P
    J Natl Cancer Inst; 2014 Apr; 106(4):dju015. PubMed ID: 24685922
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Brasky TM; Darke AK; Song X; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA; Kristal AR
    J Natl Cancer Inst; 2013 Aug; 105(15):1132-41. PubMed ID: 23843441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The A-to-Z of omega-3. Why this fatty acid is a must for good health.
    Neithercott T
    Diabetes Forecast; 2009 Feb; 62(2):45-8. PubMed ID: 19326578
    [No Abstract]   [Full Text] [Related]  

  • 18. [n-3 and n-6 fatty acids in plasma at birth and at one year and the relationship with the type of feeding].
    Moreno Villares JM
    An Pediatr (Barc); 2009 Feb; 70(2):189-90. PubMed ID: 19217578
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum omega-3 and omega-6 fatty acids and cutaneous p53 expression in an Australian population.
    van der Pols JC; Xu C; Boyle GM; Hughes MC; Carr SJ; Parsons PG; Green AC
    Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):530-6. PubMed ID: 21217086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic manifestations during childhood and fetal exposure to arachidonic acid.
    Dirix CE; Hogervorst JG; Rump P; Hendriks JJ; Bruins M; Hornstra G
    Clin Exp Allergy; 2011 Oct; 41(10):1493-4. PubMed ID: 22061485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.